ncRNA-Mediated Upregulation of AURKA Promotes Hepatocellular Carcinoma Progression and Alters the Immune Microenvironment

ncRNA介导的AURKA上调促进肝细胞癌进展并改变免疫微环境

阅读:2

Abstract

Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality worldwide. Aurora kinase A (AURKA), a critical regulator of mitosis and spindle assembly, has been implicated in tumorigenesis, yet its clinical relevance and immune associations in HCC require further clarification. Here, we performed integrated bioinformatic analyses using TCGA/GTEx-derived datasets and public platforms (including TIMER and GEPIA2) to characterize AURKA expression patterns, prognostic significance, and functional pathways in HCC. Potential upstream noncoding RNA (ncRNA) interactions were explored using ENCORI and miRNet 2.0, and immune microenvironment correlations were assessed via TIMER/GEPIA2 and TISIDB. We found that AURKA was significantly overexpressed in HCC and associated with unfavorable prognosis and more advanced clinicopathological features. A putative ncRNA regulatory axis involving DUXAP8 and hsa-miR-490-3p was identified as being associated with AURKA expression. Moreover, AURKA expression correlated with immune cell infiltration and immune-related features, suggesting a relationship with the tumor immune microenvironment. Collectively, our analyses suggest that a putative DUXAP8/hsa-miR-490-3p/AURKA regulatory network may be associated with HCC progression and correlates with features of the tumor immune microenvironment. These findings offer insight into potential biomarkers and therapeutic targets for personalized HCC treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。